AstraZeneca PLC (AZN) - Total Liabilities

Latest as of June 2026: GBX65.80 Billion GBX ≈ $8.01 Million USD

Based on the latest financial reports, AstraZeneca PLC (AZN) has total liabilities worth GBX65.80 Billion GBX (≈ $8.01 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AstraZeneca PLC long-term investment allocation to see how much of total assets are deployed in long-term investments.

AstraZeneca PLC - Total Liabilities Trend (1990–2025)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see AZN total asset value.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Air China Limited F:AD2	Germany	€303.82 Billion
Yantai Eddie Precision Mach SHG:603638	China	CN¥2.63 Billion
Ingevity Corp NYSE:NGVT	USA	$1.49 Billion
Valiant Holding AG SW:VATN	Switzerland	CHF36.26 Billion
Zhejiang Yonghe Refrigerant Co Ltd SHG:605020	China	CN¥2.96 Billion
Solaria Energía y Medio Ambiente S.A MC:SLR	Spain	€1.77 Billion
Servyou Software Group Co Ltd SHG:603171	China	CN¥1.71 Billion
FOCI Fiber Optic Communications TWO:3363	Taiwan	NT$607.99 Million

Liability Composition Analysis (1990–2025)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of AstraZeneca PLC to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.30	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (1990–2025)

The table below shows the annual total liabilities of AstraZeneca PLC from 1990 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX65.36 Billion ≈ $7.95 Million	+3.47%
2024-12-31	GBX63.16 Billion ≈ $7.69 Million	+1.95%
2023-12-31	GBX61.95 Billion ≈ $7.54 Million	+4.25%
2022-12-31	GBX59.42 Billion ≈ $7.23 Million	-10.07%
2021-12-31	GBX66.08 Billion ≈ $8.04 Million	+29.33%
2020-12-31	GBX51.09 Billion ≈ $6.22 Million	+9.21%
2019-12-31	GBX46.78 Billion ≈ $5.69 Million	+0.37%
2018-12-31	GBX46.61 Billion ≈ $5.67 Million	-0.22%
2017-12-31	GBX46.71 Billion ≈ $5.68 Million	+1.86%
2016-12-31	GBX45.86 Billion ≈ $5.58 Million	+10.19%
2015-12-31	GBX41.62 Billion ≈ $5.06 Million	+6.84%
2014-12-31	GBX38.95 Billion ≈ $4.74 Million	+19.31%
2013-12-31	GBX32.65 Billion ≈ $3.97 Million	+10.36%
2012-12-31	GBX29.58 Billion ≈ $3.60 Million	+0.76%
2011-12-31	GBX29.36 Billion ≈ $3.57 Million	-10.27%
2010-12-31	GBX32.72 Billion ≈ $3.98 Million	-4.05%
2009-12-31	GBX34.10 Billion ≈ $4.15 Million	+10.39%
2008-12-31	GBX30.89 Billion ≈ $3.76 Million	-6.51%
2007-12-31	GBX33.04 Billion ≈ $4.02 Million	+127.62%
2006-12-31	GBX14.52 Billion ≈ $1.77 Million	+30.20%
2005-12-31	GBX11.15 Billion ≈ $1.36 Million	-0.05%
2004-12-31	GBX11.15 Billion ≈ $1.36 Million	+8.13%
2003-12-31	GBX10.32 Billion ≈ $1.26 Million	-0.38%
2002-12-31	GBX10.36 Billion ≈ $1.26 Million	+16.78%
2001-12-31	GBX8.87 Billion ≈ $1.08 Million	-0.34%
2000-12-31	GBX8.90 Billion ≈ $1.08 Million	-6.04%
1999-12-31	GBX9.47 Billion ≈ $1.15 Million	+26.33%
1998-12-31	GBX7.50 Billion ≈ $912.05K	+60.91%
1997-12-31	GBX4.66 Billion ≈ $566.80K	-4.95%
1996-12-31	GBX4.90 Billion ≈ $596.33K	+1.40%
1995-12-31	GBX4.83 Billion ≈ $588.09K	+5.23%
1994-12-31	GBX4.59 Billion ≈ $558.87K	-9.94%
1993-12-31	GBX5.10 Billion ≈ $620.56K	-15.25%
1992-12-31	GBX6.02 Billion ≈ $732.24K	+10.52%
1991-12-31	GBX5.45 Billion ≈ $662.52K	+0.49%
1990-12-31	GBX5.42 Billion ≈ $659.26K	--

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.37 Billion

GBX19.48 Trillion GBX

Market Cap Rank

#5637 Global

#14 in UK

Share Price

GBX12560.00

Change (1 day)

+0.48%

52-Week Range

GBX10956.00 - GBX15542.00

All Time High

GBX15542.00